|
P 1
|
P 2
|
P 3
|
P 4
|
P 5
|
P 6
|
P 7
|
P 8
|
---|
|
(M)
|
(M)
|
(F)
|
(F)
|
(F)
|
(F)
|
(F)
|
(F)
|
LS BMD (g/cm2) at baseline
|
0.707
|
0.611
|
0.790
|
0.623
|
0.784
|
0.455
|
0.423
|
0.598
|
LS BMD (g/cm2) at 3 months
|
0.761
|
0.668
|
0.884
|
0.650
|
0.846
|
0.493
|
0.495
|
0.672
|
LS BMD (g/cm2) at 1 year
|
0.749
|
0.660
|
0.879
|
0.650
|
0.844
|
0.488
|
0.491
|
0.667
|
% change LS BMD at 3 months
|
7.6
|
9.3
|
11.9
|
4.3
|
7.9
|
8.4
|
17.0
|
12.4
|
% change LS BMD at 1 year
|
5.9
|
8.0
|
11.3
|
4.3
|
7.7
|
7.3
|
16.1
|
11.5
|
Effect on LS BMD
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
- P: Patient, (M): male, (F): female, LS: lumbar spine, BMD: bone mineral density, +: positive. The effect of cord blood mononuclear cells was considered as positive when the increase in bone mineral density was bigger than 1.5% at lumbar spine or when patients stopped loosing bone